Who owns Ironwood Pharmaceuticals?

Key details on Ironwood Pharmaceuticals (Ticker: IRWD)

Who owns Ironwood Pharmaceuticals?

Is IRWD a good stock to own? Find out who bought Ironwood Pharmaceuticals, who sold Ironwood Pharmaceuticals (IRWD) stock, and who holds a large position in Ironwood Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 19.76M $316.09M March 31, 2015
Wellington Management Company 17.53M $280.47M March 31, 2015
Janus Capital Management 14.89M $238.17M March 31, 2015
OrbiMed Advisors 12.01M $192.19M March 31, 2015
Vanguard 8.00M $127.96M March 31, 2015
MORGAN STANLEY 7.73M $118.53M Dec. 31, 2014
Deutsche Bank Aktiengesellschaft 6.67M $105.25M March 31, 2015
BlackRock Fund Advisors 5.67M $90.67M March 31, 2015
BVF 5.09M $78.04M Dec. 31, 2014
Sectoral Asset Management 4.64M $57.19M March 31, 2014
STATE STREET CORPORATION 3.36M $53.73M March 31, 2015
Waddell & Reed Financial 3.27M $32.56M June 30, 2013
BlackRock Institutional Trust Company, N.A. 3.22M $51.56M March 31, 2015
State of Wisconsin Investment Board 3.11M $49.73M March 31, 2015
Capital World Investors^ 2.92M $29.10M June 30, 2013
Ridgeback Capital Investments 2.69M $35.82M March 31, 2012
ALLIANCEBERNSTEIN 2.67M $36.77M June 30, 2012
Millennium Management 2.67M $40.87M Dec. 31, 2014
T. Rowe Price Associates 2.63M $42.08M March 31, 2015
TCW 2.42M $30.93M Sept. 30, 2012
Capital Guardian Trust Company 2.40M $28.50M Sept. 30, 2013
VHCP Management 2.40M $26.59M Dec. 31, 2012

Who sold Ironwood Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Bridger Management June 30, 2011 2.50M $39.30M
Maverick Capital March 31, 2011 3.39M $47.36M
Adage Capital Partners GP March 31, 2011 2.40M $33.60M